Ludwig-maximilians - University Of Munich
Clinical trials sponsored by Ludwig-maximilians - University Of Munich, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New tool aims to protect rights of those with memory loss Results expected Sep 2026 (estimated)
- Laser showdown: which prostate surgery works best? Results expected Sep 2026 (estimated)
- Step up to surgery: daily walks may cut bladder cancer operation risks Results expected Nov 2026 (estimated)
- Can a game app teach kids to beat the blues? Results expected Dec 2026 (estimated)
- Can a Bag-Like device pull bladder tumors out whole? Results expected Dec 2026 (estimated)
-
Can a targeted drug shrink tumors when only some cells carry the mutation?
Disease control Stopped earlyThis phase 2 trial tests whether adding panitumumab to standard chemotherapy can shrink tumors in people with metastatic colorectal cancer that has low-frequency RAS mutations. The idea is that even if a small number of cancer cells have the mutation, most cells may still respond…
Phase 2 • Sponsor: Ludwig-Maximilians - University of Munich • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Radiation plus chemo for pancreatic cancer pain: trial ends early
Symptom relief Stopped earlyThis phase 2 trial tested whether adding MR-guided radiation to standard chemotherapy could reduce pain in people with metastatic pancreatic cancer. Only 9 participants were enrolled before the study was terminated early. The main goal was to track pain scores over time, but the …
Phase 2 • Sponsor: Ludwig-Maximilians - University of Munich • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC